Novel Biomarkers and Therapeutic Approaches of Urogenital Cancers
A special issue of Applied Sciences (ISSN 2076-3417). This special issue belongs to the section "Applied Biosciences and Bioengineering".
Deadline for manuscript submissions: closed (20 August 2023) | Viewed by 142
Special Issue Editors
2. Dipartimento di Medicina di Precisione, Università degli Studi della Campania “L. Vanvitelli”, 80131 Naples, Italy
Interests: molecular oncology; microRNA; long non-coding RNA; testicular germ cell tumors
Special Issues, Collections and Topics in MDPI journals
Interests: molecular oncology; microRNA; long non-coding RNA; testicular germ cell tumors
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We are delighted to encourage you to submit a work to the Special Issue " Novel Biomarkers and Therapeutic Approaches of Urogenital Cancers". The prevalence of urological cancers has risen dramatically in the last 50 years. Although breakthroughs in medical tumor therapy, chemoresistance and metastatic disease are significant causes of mortality in urological malignancies. As a result, new biomarkers and therapeutic techniques for better diagnostic and treatment results are required. To achieve this goal, we require a greater knowledge of the molecular alterations that occur in urological malignancies, as well as the creation of molecular biomarkers capable of predicting tumor behavior, disease recurrence, and chemoresistance.
As a result, this Special Issue of Cancers encourages original research articles and reviews on urological malignancies. Communications, mini-reviews, systematic reviews, and meta-analyses will also be accepted. The articles that will be considered for publication are:
- Original studies;
- Reviews;
- Technical advancements for tumor characterization, diagnosis and treatments.
Dr. Marco De Martino
Dr. Francesco Esposito
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Applied Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- prostate cancer
- bladder cancer
- renal cell carcinoma, testicular cancer
- biomarkers
- drug delivery
- cancer treatment
